Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
Bloomberg's Tom Gibson reports on the French company making money from snakes and scorpions by selling their venom to the pharmaceutical industry.
On Air Now
The Year Ahead: Innovation
Studio 1.0: Aaron Sorkin
©2014 Bloomberg L.P. All Rights Reserved. Made in NYC